William Steven Gange

William Steven Gange

Auto-generated profile, based on publicly available information

William Steven Gange

Department of Ophthalmology, Keck School of Medicine of University of Southern California, Los Angeles, California, USA

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 July 2020 in The Ocular Surface
Verified
Journal Article
Closed access
MZMichael J. Zilliox
Michael J. Zilliox
WGWilliam S. Gange
William S. Gange
GKGina Kuffel
Gina Kuffel
CMCarine R. Mores
Carine R. Mores
CJCara Joyce
Cara Joyce
CBCharles Bouchard
Charles Bouchard

19 May 2020 in Blood Advances
Verified
Journal Article
Open access
PDF file
CDChristopher C. Denton
Christopher C. Denton
WGWilliam S. Gange
William S. Gange
HAHisham Abdel-Azim
Hisham Abdel-Azim
SJSonata Jodele
Sonata Jodele
NKNeena Kapoor
Neena Kapoor
ANAaron Nagiel
Aaron Nagiel
Key Points: CAR T-cell targeting of leukemic infiltrates in the optic nerve and retina caused retinal detachment as a presentation of pseudoprogression. Treatment of this intraocular inflammation with intravitreal triamcinolone and orbital radiation led to marked improvement in visual acuity.

1 February 2021 in Ophthalmology Retina
Verified
Journal Article
Closed access
WGWilliam S. Gange
William S. Gange
BXBenjamin Y. Xu
Benjamin Y. Xu
KLKhristina Lung
Khristina Lung
BTBrian C. Toy
Brian C. Toy
SSSeth A. Seabury
Seth A. Seabury

3 May 2017 in Operative Neurosurgery
Verified
Journal Article
Closed access
PDF file
WGWilliam S Gange
William S Gange
IKIan D Kirchner
Ian D Kirchner
JTJohn A Thompson
John A Thompson
JHJacquelyn Hill
Jacquelyn Hill
KGKurt Grahnke
Kurt Grahnke
CBCharles S Bouchard
Charles S Bouchard
BACKGROUND: Past studies have shown high rates of ocular complications with the need for ophthalmic surgery following acoustic neuroma resection (ANR). OBJECTIVE: To determine the rates of ophthalmic complications, referrals, and surgery following ANR, and the factors associated with poor outcomes. METHODS: A retrospective study of ophthalmic outcomes in patients who underwent ANR was conducted, following institutional review board approval. Surgical approach, tumor size, tumor characteristics, completeness of resection, postoperative House-Brackmann grades, ocular complications, referrals to ophthalmology, and ophthalmic treatments were recorded. RESULTS: Between 2007 and 2012, 174 patients underwent ANR. There were 3 surgical groups: retrosigmoid (n = 97), translabyrinthine (n = 59), and combined retrosigmoid and translabyrinthine (n = 18). Median tumor size was 2.2 cm. Postoperatively, 30% of patients had facial nerve dysfunction (House-Brackmann ≥3), which recovered to 19% by 1 mo and 8.6% by 1 yr following ANR. Fifty-six (32.9%) patients experienced ocular complications postoperatively, with lagophthalmos, dry eye, and blurry vision as the most common complications. Thirty-six (67.9%) of the patients who required ophthalmic treatment were managed nonsurgically, with just 13 (7.6%) patients requiring referral to an ophthalmologist. In total, only 9 (5.3%) patients received an ophthalmic procedure. Patients with tumors >2 cm, those undergoing combined retrosigmoid and translabyrinthine resection, and those with severe facial nerve dysfunction which did not improve in the first month following surgery were more likely to have poor ophthalmic outcomes. CONCLUSION: We present lower rates of ophthalmic complications following ANR than previously reported. Improved surgical technique, better postoperative eye care, and facial nerve monitoring most likely accounted for the improved ocular outcomes.

1 October 2018 in Current Urology
Verified
Journal Article
Open access
PDF file
JSJennifer L. Saluk
Jennifer L. Saluk
RBRobert H. Blackwell
Robert H. Blackwell
WGWilliam S. Gange
William S. Gange
MZMatthew A. C. Zapf
Matthew A. C. Zapf
AKAnai N. Kothari
Anai N. Kothari
GGGopal Gupta
Gopal Gupta
Introduction: Radical cystectomy for bladder cancer is associated with high rates of readmission. We investigated the LACE score, a validated prediction tool for readmission and mortality, in the radical cystectomy population. Materials & Methods: Patients who underwent radical cystectomy for bladder cancer were identified by ICD-9 codes from the Healthcare Cost and Utilization Project State Inpatient Database for California years 2007-2010. The LACE score was calculated as previously described, with components of L: length of stay, A: acuity of admission, C: comorbidity, and E: number of emergency department visits within 6 months preceding surgery. Results: Of 3,470 radical cystectomy patients, 638 (18.4%) experienced 90-day readmission, and 160 (4.6%) 90-day mortality. At a previously validated “high-risk” LACE score ≥ 10, patients experienced an increased risk of 90-day readmission (22.8 vs. 17.7%, p = 0.002) and mortality (9.1 vs. 3.5%, p < 0.001). On adjusted multivariable analysis, “high risk” patients by LACE score had increased 90-day odds of readmission (adjusted OR = 1.24, 95% CI: 0.99-1.54, p = 0.050) and mortality (adjusted OR = 2.09, 95% CI: 1.47-2.99, p < 0.001). Conclusion: The LACE score reasonably identifies patients at risk for 90-day mortality following radical cystectomy, but only poorly predicts readmission. Providers may use the LACE score to target high-risk patients for closer follow-up or intervention.

1 January 2019 in RETINAL Cases & Brief Reports
Verified
Journal Article
Closed access
PDF file
WGWilliam S. Gange
William S. Gange
SHStephen M. Holland
Stephen M. Holland
FAFelipe De Alba
Felipe De Alba
Purpose: To report a case of IgG4-related ophthalmic disease (IgG4-ROD) which presented as choroidal and orbital lesions. Methods: Case report. Results: A 64-year-old man presented with left eye photopsias and a history of IgG4-related perirenal fibrosis. Fundoscopic examination showed multiple bilateral yellow choroidal lesions, and optical coherence tomography showed multiple choroidal lesions. Magnetic resonance imaging of the orbits showed an enhancing lesion present circumferential to the optic nerve, but greater medially, abutting the posterior surface of the left globe. Workup for infectious, autoimmune, and malignant etiologies was negative, and the patient has responded well to treatment with rituximab. Conclusion: IgG4-related disease is a systemic fibroinflammatory disease, which often presents in another location, as in our patient. In cases of uncertain choroidal and orbital lesions, a thorough workup for other etiologies is indicated, and lymphoma must be ruled out. Steroids are the mainstay of treatment for IgG4-ROD, however, small case series and our patient responded well to rituximab. To our knowledge, this is the first reported case of choroidal and orbital lesions secondary to IgG4-ROD.